Amarin Corp PLC (AMRN)
0.87
-0.04
(-4.65%)
USD |
NASDAQ |
May 17, 16:00
0.8761
+0.01
(+0.70%)
After-Hours: 20:00
Amarin Gross Profit (Quarterly): 31.90M for March 31, 2024
Gross Profit (Quarterly) Chart
Historical Gross Profit (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 31.90M |
December 31, 2023 | 45.12M |
September 30, 2023 | 29.82M |
June 30, 2023 | 42.67M |
March 31, 2023 | 47.93M |
December 31, 2022 | 63.60M |
September 30, 2022 | 62.86M |
June 30, 2022 | 43.63M |
March 31, 2022 | 72.39M |
December 31, 2021 | 113.86M |
September 30, 2021 | 111.83M |
June 30, 2021 | 122.33M |
March 31, 2021 | 113.84M |
December 31, 2020 | 132.48M |
September 30, 2020 | 123.43M |
June 30, 2020 | 106.52M |
March 31, 2020 | 120.19M |
December 31, 2019 | 112.61M |
September 30, 2019 | 86.96M |
June 30, 2019 | 78.02M |
March 31, 2019 | 56.14M |
December 31, 2018 | 59.82M |
September 30, 2018 | 41.78M |
June 30, 2018 | 39.80M |
March 31, 2018 | 33.27M |
Date | Value |
---|---|
December 31, 2017 | 40.43M |
September 30, 2017 | 35.44M |
June 30, 2017 | 33.84M |
March 31, 2017 | 26.44M |
December 31, 2016 | 28.54M |
September 30, 2016 | 24.28M |
June 30, 2016 | 24.25M |
March 31, 2016 | 18.65M |
December 31, 2015 | 18.24M |
September 30, 2015 | 14.00M |
June 30, 2015 | 11.33M |
March 31, 2015 | 10.31M |
December 31, 2014 | 10.63M |
September 30, 2014 | 8.783M |
June 30, 2014 | 7.581M |
March 31, 2014 | 6.721M |
December 31, 2013 | 6.007M |
September 30, 2013 | 4.721M |
June 30, 2013 | 2.656M |
March 31, 2013 | 1.054M |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Quarterly) Range, Past 5 Years
29.82M
Minimum
Sep 2023
132.48M
Maximum
Dec 2020
83.10M
Average
82.49M
Median
Gross Profit (Quarterly) Benchmarks
Trinity Biotech PLC | 4.567M |
Avadel Pharmaceuticals PLC | 25.66M |
DBV Technologies SA | -- |
Cellectis SA | 0.116M |
Adaptimmune Therapeutics PLC | -- |